Targeting the embryonic gene Cripto-1 in cancer and beyond

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.20, Iss.12, 2010-12, pp. : 1739-1749

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting DAX-1 in embryonic stem cells and cancer

By Lalli Enzo Alonso Javier

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. : 169-177

Informa Healthcare

Access to resources Recommend Favorite

Cripto as a target for cancer immunotherapy

By Hu Xiu Feng Xing Pei Xiang

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 383-394

Informa Healthcare

Access to resources Recommend Favorite

Targeting PDK1 in Cancer

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2763-2769

Bentham Science Publishers

Access to resources Recommend Favorite

Gas1 is a Pleiotropic Regulator of Cellular Functions: from Embryonic Development to Molecular Actions in Cancer Gene Therapy

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 14, 2014-12 ,pp. : 1139-1147

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Gene Therapy for Prostate Cancer

Current Pharmaceutical Design, Vol. 10, Iss. 5, 2004-01 ,pp. : 531-555

Bentham Science Publishers

Access to resources Recommend Favorite